ENTtoday
  • Home
  • Practice Focus
    • Allergy
    • Facial Plastic/Reconstructive
    • Head and Neck
    • Laryngology
    • Otology/Neurotology
    • Pediatric
    • Rhinology
    • Sleep Medicine
  • Departments
    • Issue Archive
    • TRIO Best Practices
      • Allergy
      • Facial Plastic/Reconstructive
      • Head and Neck
      • Laryngology
      • Otology/Neurotology
      • Pediatric
      • Rhinology
      • Sleep Medicine
    • Career Development
    • Case of the Month
    • Everyday Ethics
    • Health Policy
    • Legal Matters
    • Medical Education
    • Online Exclusives
    • Practice Management
    • Resident Focus
    • Special Reports
    • Tech Talk
    • Viewpoint
  • Literature Reviews
    • Allergy
    • Facial Plastic/Reconstructive
    • Head and Neck
    • Laryngology
    • Otology/Neurotology
    • Pediatric
    • Rhinology
    • Sleep Medicine
  • Multimedia
    • Video
    • Audio
  • Events
    • Featured Events
    • TRIO Meetings
  • Contact Us
    • About Us
    • Editorial Board
    • Triological Society
    • Advertising Staff
    • Subscribe
    • eNewsletters
  • Advertise
    • Place an Ad
    • Classifieds
    • Rate Card
  • Search

New Excise Tax Applicable to Otolaryngologist Devices

by Amy Eckner • November 1, 2012

  • Tweet
  • Email
Print-Friendly Version

According to Benner, it generally takes between four and seven years for a device to go from initial concept to commercial development—a time when a manufacturer could go through $60 to $100 million in development costs, with no profits coming in. “An excise tax will drastically affect these kinds of companies,” he said.

You might also like:

  • When Dealing with Insurers, Electronic Payment Tools May be an Otolaryngologist’s Best Friend
  • Mobile Devices in the Medical Setting Can Lead to Distracted Doctors and Medical Error
  • How Will the Affordable Care Act Impact Otolaryngology?
  • The Otolaryngologist and the Imminent Crisis in Geriatric Medicine
Explore this issue:
November 2012

Raising the cost and timeline of developing new devices could mean that clinicians outside the U.S. might have tools available that are too expensive to market within the country. “Today, the impact might be a higher jobless rate, but down the road, there may not be the same level of technology and devices available,” said Benner.

While the future of the ACA is still uncertain, it’s unlikely that this particular provision will be repealed before going into effect at the beginning of the year.

ENT Medical Devices Subject to Tax

The U.S. government separates ear, nose and throat devices into three classes. Class I devices are exempt from the tax. Class II devices are subject to the tax unless they are marketed directly to consumers and cost less than $100 per unit. Class III devices are subject to the tax.

Below are Class II and III devices for otolaryngology devices according to the Federal Food, Drug, and Cosmetic Act:

CLASS II

  • Argon laser for otology, rhinology and laryngology
  • Audiometer
  • Auditory impedance tester
  • Bone conduction hearing aid
  • Bronchoscope (flexible or rigid) and accessories
  • Ear, nose and throat electric or pneumatic surgical drill
  • Ear, nose and throat microsurgical carbon dioxide laser
  • Ear, nose and throat synthetic polymer material
  • Electroglottograph
  • Electronic noise generator for audiometric testing
  • Endolymphatic shunt
  • Endolymphatic shunt tube with valve
  • Esophagoscope (flexible or rigid) and accessories
  • Group hearing aid or group auditory trainer
  • Hearing aid calibrator and analysis system
  • Laryngeal prosthesis (Taub design)
  • Laryngostroboscope
  • Mandibular implant facial prosthesis
  • Master hearing aid
  • Mediastinoscope and accessories
  • Middle ear mold
  • Nasopharyngoscope (flexible or rigid) and accessories
  • Olfactory test device
  • Partial ossicular replacement prosthesis
  • Sacculotomy tack (Cody tack)
  • Surgical nerve stimulator/locator
  • Tinnitus masker
  • Total ossicular replacement prosthesis
  • Transcutaneous air conduction hearing aid system
  • Tympanostomy tube
  • Tympanostomy tube with semipermeable membrane

CLASS III

  • Suction antichoke device
  • Tongs antichoke device

Pages: 1 2 Single Page

Filed Under: Departments, Health Policy, Practice Management, Tech Talk Tagged With: affordable care act, billing and coding, ENT medical device, healthcare reform, policy, tax, technologyIssue: November 2012

You might also like:

  • When Dealing with Insurers, Electronic Payment Tools May be an Otolaryngologist’s Best Friend
  • Mobile Devices in the Medical Setting Can Lead to Distracted Doctors and Medical Error
  • How Will the Affordable Care Act Impact Otolaryngology?
  • The Otolaryngologist and the Imminent Crisis in Geriatric Medicine

The Triological SocietyENTtoday is a publication of The Triological Society.

The Laryngoscope
Ensure you have all the latest research at your fingertips; Subscribe to The Laryngoscope today!

Laryngoscope Investigative Otolaryngology
Open access journal in otolaryngology – head and neck surgery is currently accepting submissions.

Classifieds

View the classified ads »

TRIO Best Practices

View the TRIO Best Practices »

Meeting Posters

View posters from Triological Society’s Meetings at TrioMeetingPosters.org

Top Articles for Residents

  • Ethical Implications of Burnout in Otolaryngology Residents
  • How Physicians Can Plan for Maternity Leave
  • Would Physicians Perform Better if They Didn’t Have to Memorize?
  • Leadership Position, Training Can Change Way Otolaryngologists Practice Medicine
  • Sleep Fellowship Training Programs on the Rise
  • Popular this Week
  • Most Popular
  • Most Recent
    • New Developments in the Management of Eustachian Tube Dysfunction
    • Vertigo in the Elderly: What Does It Mean?
    • Eustachian Tuboplasty: A Potential New Option for Chronic Tube Dysfunction and Patulous Disease
    • Some Laryngopharyngeal Reflux Resists PPI Treatment
    • Ménière’s Disease-Don’t Blame the Patient
    • Eustachian Tuboplasty: A Potential New Option for Chronic Tube Dysfunction and Patulous Disease
    • New Developments in the Management of Eustachian Tube Dysfunction
    • Some Laryngopharyngeal Reflux Resists PPI Treatment
    • Vertigo in the Elderly: What Does It Mean?
    • Post-Operative Pain in Children Undergoing Tonsillectomy
    • Sleep Disorders Affect Men and Women Differently
    • Drug Shrinks Multiple Cancer Tumor Types with Same Genetic Defect
    • Report: Physician Prescribing Behavior Changes Following Restrictions on Direct Marketing
    • Experts Discuss Approaches to Aging Cases
    • Otolaryngology Community Comes Together for Education and Collaboration

Polls

Is direct-to-consumer genetic testing a good idea?

View Results

Loading ... Loading ...
  • Polls Archive
  • Home
  • Contact Us
  • Advertise
  • Privacy Policy

Visit: The Triological Society • The Laryngoscope • Triological Meeting Posters

Wiley
© 2017 The Triological Society. All Rights Reserved.
ISSN 1559-4939
loading Cancel
Post was not sent - check your email addresses!
Email check failed, please try again
Sorry, your blog cannot share posts by email.